MARK VANN: Open Payments
NPI 1194036327 · DECHERD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 50 payments from 19 companies in 2025. Trend: 2023 $853 · 2024 $976 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $125 |
| Lundbeck LLC | 4 | $91 |
| PFIZER INC. | 5 | $89 |
| AngioDynamics, Inc. | 1 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Astellas Pharma US Inc | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Lilly USA, LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $43 |
Products named: REXULTI, CAPLYTA, NURTEC ODT, AURYON LASER SYSTEM 100-120 VAC, QULIPTA, Veozah, VRAYLAR, MOUNJARO.
Industry payments across TN — which companies pay providers there.
